{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT01286519",
            "orgStudyIdInfo": {
                "id": "10-0865"
            },
            "organization": {
                "fullName": "University of North Carolina, Chapel Hill",
                "class": "OTHER"
            },
            "briefTitle": "Pharmacokinetics of Off Label Pediatric Medications",
            "officialTitle": "Pharmacokinetics of Off Label Pediatric Medications",
            "therapeuticArea": [
                "Pediatrics"
            ],
            "study": "pharmacokinetics-of-off-label-pediatric-medications"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-04",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2010-07",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2035-12",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2035-12",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2011-01-21",
            "studyFirstSubmitQcDate": "2011-01-28",
            "studyFirstPostDateStruct": {
                "date": "2011-01-31",
                "type": "ESTIMATED"
            },
            "lastUpdateSubmitDate": "2024-05-20",
            "lastUpdatePostDateStruct": {
                "date": "2024-05-22",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "University of North Carolina, Chapel Hill",
                "class": "OTHER"
            }
        },
        "oversightModule": {
            "oversightHasDmc": false
        },
        "descriptionModule": {
            "briefSummary": "The purpose of this study is to measure the level of medicines found in body fluids such as blood, urine, spinal fluid of children.",
            "detailedDescription": "There is a lack of safety, pharmacokinetic and efficacy data of therapeutic agents in children and infants. Samples used for measurement will be from scavenged samples. i.e. any extra blood/body fluid samples from a test done as part of the standard of care."
        },
        "conditionsModule": {
            "conditions": [
                "Off Label Use of Medications in Pediatric Patients"
            ],
            "keywords": [
                "pharmacokinetics"
            ]
        },
        "designModule": {
            "studyType": "OBSERVATIONAL",
            "designInfo": {
                "observationalModel": "CASE_ONLY",
                "timePerspective": "PROSPECTIVE"
            },
            "enrollmentInfo": {
                "count": 400,
                "type": "ESTIMATED"
            }
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Area under the curve (AUC)",
                    "description": "actual body exposure to drug after a dose of the drug is administered. this is dependent on on the rate of drug elimination divided by plasma concentration of the drug.",
                    "timeFrame": "approximately 10-21 days.The time frame for the outcome measure may vary depending on the length of the course of the medication."
                },
                {
                    "measure": "Volume of distribution at steady-state",
                    "description": "Volume of distribution is defined as the theoretical volume in which the total amount of drug would need to be uniformly distributed to produce the desired blood concentration of a drug. Vss is the apparent volume of distribution at steady-state.",
                    "timeFrame": "approximately 10-21 days. The time frame for the outcome measure may vary depending on the length of the course of the medication."
                },
                {
                    "measure": "Terminal elimination rate constant (Ke) and Half-Life",
                    "description": "Period of time that it takes for the concentration of the drug in the body to be reduced by on-half.",
                    "timeFrame": "approximately 10-21 days. The time frame for the outcome measure may vary depending on the length of the course of the medication."
                },
                {
                    "measure": "Plasma Clearance",
                    "description": "the rate at which the drug is eliminated from the body divided by the plasma concentration.",
                    "timeFrame": "approximately 10-21 days. The time frame for the outcome measure may vary depending on the length of the course of the medication."
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Children less than 8 years of age\n* Receiving a therapeutic agent at a dose or for an indication not currently included on the FDA label as part of standard of care\n\nExclusion Criteria:\n\n* Lack of consent",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "1 Day",
            "maximumAge": "8 Years",
            "stdAges": [
                "CHILD"
            ],
            "studyPopulation": "children \\< 8 years of age currently receiving a therapeutic agent at a dose or for an indication not currently included on the FDA label as part of standard of care",
            "samplingMethod": "NON_PROBABILITY_SAMPLE"
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Sneha Makhijani, BS",
                    "role": "CONTACT",
                    "phone": "(984) 974-7865",
                    "email": "sneha_makhijani@med.unc.edu"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Matthew M. Laughon, MD, MPH",
                    "affiliation": "University of North Carolina",
                    "role": "PRINCIPAL_INVESTIGATOR"
                }
            ],
            "locations": [
                {
                    "facility": "University of North Carolina NC Children's Hospital",
                    "status": "RECRUITING",
                    "city": "Chapel Hill",
                    "state": "North Carolina",
                    "zip": "27514",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Sneha Makhijani, MS, RN",
                            "role": "CONTACT",
                            "phone": "984-974-7865",
                            "email": "sneha_makhijani@med.unc.edu"
                        },
                        {
                            "name": "Matthew M Laughon, MD, MPH",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 35.9132,
                        "lon": -79.05584
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        }
    },
    "hasResults": false
}